The PentaHibe® Complete is a new addition to Pharmacosmos’ cryopreservation formulations portfolio. The company says PentaHibe Complete is a ready-to-use cGMP-compliant formulation that can be used with a range of cell types. It is designed with 10% pentaisomaltose and 2% DMSO as cryoprotective agents to reduce DMSO-related toxicity and side effects. The company states that the PentaHibe Complete has been tested across various cell types, including T cells, mesenchymal stem cells, hematopoietic stem cells, CHO cells, and HEK cells.